Oramed Pharmaceuticals
ORMP
#8933
Rank
A$0.15 B
Marketcap
$3.79
Share price
-4.82%
Change (1 day)
8.22%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): A$36.67 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of A$11.38 Million, an increase over its 2022 earnings that were of -A$58.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$36.67 M222.1%
2023 A$11.38 M-119.45%
2022 -A$58.54 Million39.17%
2021 -A$42.06 Million73.93%
2020 -A$24.19 Million18.53%
2019 -A$20.41 Million-16.62%
2018 -A$24.47 Million38.32%
2017 -A$17.69 Million12.51%
2016 -A$15.73 Million25.01%
2015 -A$12.58 Million18.18%
2014 -A$10.65 Million39.72%
2013 -A$7.62 Million46.4%
2012 -A$5.21 Million128.32%
2011 -A$2.28 Million-51.47%
2010 -A$4.7 Million35.21%
2009 -A$3.48 Million
2007 -A$5.47 Million607.04%
2006 -A$0.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.8 Billion-2,113.66%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.51 B 72,308.80%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
A$11.83 B 29,960.63%๐Ÿ‡ซ๐Ÿ‡ท France
A$24.16 M-38.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-A$0.35 Billion-978.11%๐Ÿ‡บ๐Ÿ‡ธ USA